Live news related to BIOMERIEUX stock (FR0013280286): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
bioMérieux's stock fell this Thursday at the close, down 2.77% to 105.40 euros. This decline came two days after the company's downward revision of it…
bioMérieux has announced a 7.3% increase in organic sales growth for the first nine months of the year, reaching 2,992 million euros, according to the…
Oxford Nanopore Technologies and bioMérieux have announced the launch of AmPORE-TB, a research use only (RUO) solution aimed at rapidly detecting muta…
On Wednesday, October 22nd, BIOMERIEUX stock rose by 3.27%, closing at €113.70, despite a generally unfavorable market environment, with the CAC 40 in…
bioMérieux's in vitro diagnostics specialist shares ended the session at €109.30, a decline of 4.79% from the previous day's €114.80. This drop, which…
